202 related articles for article (PubMed ID: 18075279)
1. Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and treatment.
Chang MY; Ong AC
Nephron Physiol; 2008; 108(1):p1-7. PubMed ID: 18075279
[TBL] [Abstract][Full Text] [Related]
2. The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease: recent advances.
Grantham JJ
Am J Kidney Dis; 1996 Dec; 28(6):788-803. PubMed ID: 8957030
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in autosomal-dominant polycystic kidney disease.
Rangan GK; Tchan MC; Tong A; Wong AT; Nankivell BJ
Intern Med J; 2016 Aug; 46(8):883-92. PubMed ID: 27553994
[TBL] [Abstract][Full Text] [Related]
5. The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.
Grantham JJ
Trans Am Clin Climatol Assoc; 2002; 113():211-24; discussion 224-6. PubMed ID: 12053711
[TBL] [Abstract][Full Text] [Related]
6. A tale of two tails: ciliary mechanotransduction in ADPKD.
Cantiello HF
Trends Mol Med; 2003 Jun; 9(6):234-6. PubMed ID: 12829010
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of Gene Therapies in Autosomal Dominant Polycystic Kidney Disease.
Xu Y; Li A; Wu G; Liang C
Curr Gene Ther; 2017; 17(1):43-49. PubMed ID: 28494735
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis of autosomal dominant polycystic kidney disease.
Yoder BK; Mulroy S; Eustace H; Boucher C; Sandford R
Expert Rev Mol Med; 2006 Jan; 8(2):1-22. PubMed ID: 16515728
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
Boucher C; Sandford R
Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
[TBL] [Abstract][Full Text] [Related]
10. Autosomal Dominant Polycystic Kidney Disease: A Path Forward.
Rangan GK; Lopez-Vargas P; Nankivell BJ; Tchan M; Tong A; Tunnicliffe DJ; Savige J
Semin Nephrol; 2015 Nov; 35(6):524-37. PubMed ID: 26718155
[TBL] [Abstract][Full Text] [Related]
11. Multidrug therapy for polycystic kidney disease: a review and perspective.
Aguiari G; Catizone L; Del Senno L
Am J Nephrol; 2013; 37(2):175-82. PubMed ID: 23428809
[TBL] [Abstract][Full Text] [Related]
12. In vitro cyst formation of ADPKD cells.
Sharma M; Reif GA; Wallace DP
Methods Cell Biol; 2019; 153():93-111. PubMed ID: 31395386
[TBL] [Abstract][Full Text] [Related]
13. Ciliary Mechanisms of Cyst Formation in Polycystic Kidney Disease.
Ma M; Gallagher AR; Somlo S
Cold Spring Harb Perspect Biol; 2017 Nov; 9(11):. PubMed ID: 28320755
[TBL] [Abstract][Full Text] [Related]
14. [Pathophysiology, epidemiology, clinical presentation, diagnosis and treatment options for autosomal dominant polycystic kidney disease].
Noël N; Rieu P
Nephrol Ther; 2015 Jul; 11(4):213-25. PubMed ID: 26113401
[TBL] [Abstract][Full Text] [Related]
15. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
16. Holding open the door reveals a new view of polycystin channel function.
Caplan MJ
EMBO Rep; 2019 Nov; 20(11):e49156. PubMed ID: 31556469
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ciliary trafficking of polycystin-2 and the pathogenesis of autosomal dominant polycystic kidney disease.
Cai Y; Tang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Feb; 35(2):93-9. PubMed ID: 20197605
[TBL] [Abstract][Full Text] [Related]
18. From bone abnormalities to mineral metabolism dysregulation in autosomal dominant polycystic kidney disease.
Mekahli D; Bacchetta J
Pediatr Nephrol; 2013 Nov; 28(11):2089-96. PubMed ID: 23340856
[TBL] [Abstract][Full Text] [Related]
19. Autosomal dominant policystic kidney disease, more than a renal disease.
Torra R
Minerva Endocrinol; 2014 Jun; 39(2):79-87. PubMed ID: 24736482
[TBL] [Abstract][Full Text] [Related]
20. Berberine slows cell growth in autosomal dominant polycystic kidney disease cells.
Bonon A; Mangolini A; Pinton P; Del Senno L; Aguiari G
Biochem Biophys Res Commun; 2013 Nov; 441(3):668-74. PubMed ID: 24184483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
